Summary
SEQUOIA GM is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €66.0m and a net result of -€1.5m. Equity remains stable across the filed financial years (±0.8% per year). Its solvency ranks better than 44% of 3,022 sector peers (NACE 64, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
2 holdings · 10 subsidiaries in the treeHoldings 2
Source for every holding own accounts 2025
-
100%
- Myco-investsubsidiaryEquity €53.0mResult €1.2m99.99%
All subsidiaries, including indirect ones 10
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
PEATINVEST 100%7 subsidiaries
- Agaris France SAS BOFR 100%
- Agaris Poland Sp ZOO BOPL 100%
- AGROFINO TRANSPORT 100%
- NORLAND 100%
- AGARIS BELGIUM 99.99%
- Agaris Latvia AS BOLV 99.25%
- JCS Peat Enterprise Nesterovskoie BORU 84.65%
Myco-invest 99.99%1 subsidiary
- Agaris Mycoculture Poland S.p.o.oPL 100%
According to the 2025 annual accounts of SEQUOIA GM and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.